[Em-02-3] Stem Cell Therapy from Acute to Chronic Stroke Patients
Asian countries are the emerging area of the world not only in economy and culture, but also neurology and neurosceince. This symposium focuses on several neurology topics especially emerging areas of neurology in the emerging Asian countries. Session 1 will focus on Stroke and the Neurosciences with world famous neuroogists and neuroscientists from Asia and USA. Session 2 will focus on Dementia and stem cell therapy with world famous neuroogists and neuroscientists again from Asia and USA.
Educational Background
1998.10-2000.5 Master of Medical Management, Tulane University, U.S.A.
1986.08-1989.08 Ph.D., Program: Graduate Student, Dept. Physiology and Biophysics, and Dept. Neurological Surgery, State University of New York at Stony Brook. U.S.A.
1980.07-1986.06 Neurosurgical Board Program:
Residency in Neurosurgery,
Tri-Service General Hospital, Taipei, Taiwan.
1973.08-1980.06 Medical Education (M.D. Program)
National Defense Medical Center, Taipei, Taiwan.
Professional Experience
HOSPITAL ADMINISTRATOR
2016/7 ~present Superintendent: Hualien Tzu Chi Hospital, Hualien, Taiwan
ACADEMIC APPOINTMENT
2016/7 ~ present Professor: Tzu Chi University, Hualien, Taiwan
Professional Organizations
2016.2-present Fellow of American Association for the Advancement of Science (AAAS)
2015-present International Fellow of American Association of Neurological Surgery (AANS),
2013-present Charter Fellow of National Academy of Inventors USA (NAI)
2011.12-2013.12 President, Taiwan Neurosurgical Society
2012-2014 President, Asia Pacific Society of Neuroregeneration,
Main Scientific Publications in 2019
Dr. Lin has published 380 scientific papers, 28 books, 64 patents transferred to partner companies, clinical trials for malignant brain tumors. In addition, 34 clinical trials have been implemented since 1996. Five "first in human trials" are currently underway.
抄録パスワード認証
パスワードは抄録集に記載してあります。